Mode
Text Size
Log in / Sign up

Multiple congenital anomalies-hypotonia-seizures syndrome 2 (MCAHS2)

Part of Epilepsy

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Epilepsy

Related studies from across the Epilepsy family.

Higher levels of dissociative symptoms observed in individuals with functional neurological disorder
Psychiatry Case-Control
Higher levels of dissociative symptoms observed in individuals with functional neurological disorder People with FND experience higher levels of dissociation
This pilot study used ecological momentary assessment to compare symptoms between individuals with functional neurological disorder and heal…
New tracking data shows that individuals living with functional neurological disorder report significantly more dissociative symptoms during…
Diagnostic accuracy study of EEG network measures for epilepsy versus functional seizures
Neurology
Diagnostic accuracy study of EEG network measures for epilepsy versus functional seizures EEG Network Measures May Help Distinguish Epilepsy From Functional Seizures
This diagnostic accuracy study evaluated multivariate resting-state EEG network measures in 148 individuals with suspected seizure disorders…
EEG network measures can distinguish epilepsy from functional seizures with 67.5% accuracy, offering a new tool to help doctors diagnose sei…
Genetic mutations in febrile sensitivity epilepsy correlate with earlier onset and specific diagnoses in children
Neurology Cohort
Genetic mutations in febrile sensitivity epilepsy correlate with earlier onset and specific diagnoses in children Fever-Triggered Seizures in Children Trace Back to Specific Genes
This retrospective cohort study examined 30 gene-positive cases and 31 gene-negative controls at Wuxi Children's Hospital.
Half of children with fever-triggered seizures carry specific gene mutations that help doctors predict which treatments will work and which …
FDA Approves Lamotrigine Tablets (lamotrigine) for Epilepsy and Bipolar Disorder Maintenance
Neurology FDA Approval
FDA Approves Lamotrigine Tablets (lamotrigine) for Epilepsy and Bipolar Disorder Maintenance The FDA has approved a drug called lamotrigine for epilepsy and bipolar disorder treatment
Lamotrigine tablets were approved as adjunctive therapy for partial-onset seizures, PGTC seizures, and Lennox-Gastaut syndrome in patients a…
The FDA has approved lamotrigine to help control seizures in children as young as two and maintain mood stability for adults with bipolar di…
FDA Approves Levetiracetam for Partial-Onset, Myoclonic, and Primary Generalized Tonic-Clonic Seizures
Neurology FDA Approval
FDA Approves Levetiracetam for Partial-Onset, Myoclonic, and Primary Generalized Tonic-Clonic Seizures FDA approves a seizure medicine called levetiracetam for children and adults
Levetiracetam is approved for the treatment of partial-onset seizures in patients 1 month and older, and as adjunctive therapy for myoclonic…
The FDA now approves levetiracetam for children as young as one month and adults to treat specific seizure types.
FDA Approves Gabapentin Capsules (gabapentin) for Postherpetic Neuralgia and Partial Onset Seizures
Neurology FDA Approval
FDA Approves Gabapentin Capsules (gabapentin) for Postherpetic Neuralgia and Partial Onset Seizures FDA approves a new generic version of the drug gabapentin for nerve pain and seizures
The FDA has approved Gabapentin Capsules, USP for the management of postherpetic neuralgia in adults and as adjunctive therapy for partial o…
FDA approves a new generic gabapentin capsule for nerve pain and seizures, offering patients another low-cost treatment option alongside exi…